imatinib mesylate has been researched along with Spinal Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elswood, TR; Hoban, K; Klejnow, EV; Nixon, I | 1 |
| Bindal, P; Noor, A; Ramirez, M; Vredenburgh, J | 1 |
| Al Asad, O; Alawin, I; Nawgiri, R; Saraireh, H; Tayyem, O | 1 |
| Akgül Babacan, N; Akin Telli, T; Alan, O; Basoglu Tuylu, T; Dane, F; Ercelep, O; Hasanov, R; Kaya, S; Mutis, A; Tanrikulu Simsek, E; Yumuk, PF | 1 |
| Brich, S; Casale, A; Casali, PG; Cavalleri, A; Collini, P; Dinoi, G; Frezza, AM; Gronchi, A; Lo Vullo, S; Mariani, L; Messina, A; Morelli, D; Morosi, C; Palassini, E; Pilotti, S; Stacchiotti, S; Tamborini, E; Venturelli, E | 1 |
| Agopian, J; Bertucci, F; Chauvot de Beauchêne, I; De Sepulveda, P; Dubreuil, P; Fouet, B; Fournier, B; Mescam-Mancini, L; Panel, N; Tchertanov, L; Tisserand, JC; Vita, M | 1 |
| Casali, PG; Crippa, F; Gronchi, A; Marrari, A; Messina, A; Morosi, C; Palassini, E; Pilotti, S; Stacchiotti, S; Tamborini, E; Virdis, E | 1 |
| Akcakaya, MO; Aras, Y; Bilgic, B; Unal, OF; Unal, SN | 1 |
| Alexis, JB; Lutzky, J; Martinez, AE | 1 |
| Casali, PG; Gronchi, A; Olmi, P; Sangalli, C; Stacchiotti, S | 1 |
4 review(s) available for imatinib mesylate and Spinal Neoplasms
| Article | Year |
|---|---|
Chordoma: A Case Report and Review of Literature.
Topics: Afatinib; Aged; Antineoplastic Agents; Chordoma; Combined Modality Therapy; Female; Head and Neck Neoplasms; Hoarseness; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Spinal Neoplasms | 2020 |
A Rare Case of a Metastatic Gastrointestinal Stromal Tumor (GIST): a Case Report and Review of the Literature.
Topics: Biopsy; Cervical Vertebrae; Colonoscopy; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Rectum; Spinal Neoplasms; Tomography, X-Ray Computed | 2019 |
Chordoma: a case series and review of the literature.
Topics: Adult; Aged; Bone Neoplasms; Chordoma; Cranial Fossa, Posterior; Female; Humans; Imatinib Mesylate; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Sacrum; Skull Base Neoplasms; Spinal Neoplasms; Sunitinib | 2018 |
Chordoma.
Topics: Antineoplastic Agents; Benzamides; Chordoma; Humans; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Sacrococcygeal Region; Skull Base Neoplasms; Spinal Neoplasms | 2007 |
2 trial(s) available for imatinib mesylate and Spinal Neoplasms
| Article | Year |
|---|---|
Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chordoma; Disease Progression; Everolimus; Female; Follow-Up Studies; Humans; Imatinib Mesylate; Male; Middle Aged; Sarcoma; Skull Base Neoplasms; Spinal Neoplasms; Survival Analysis | 2018 |
Response to imatinib plus sirolimus in advanced chordoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blotting, Western; Chordoma; Female; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Middle Aged; Oncogene Protein v-akt; Piperazines; Pyrimidines; Sacrum; Sirolimus; Skull Base Neoplasms; Spinal Neoplasms; Treatment Outcome; Young Adult | 2009 |
4 other study(ies) available for imatinib mesylate and Spinal Neoplasms
| Article | Year |
|---|---|
Metastatic chordoma with pancreatic disease and response to imatinib.
Topics: Cervical Vertebrae; Chordoma; Female; Humans; Imatinib Mesylate; Middle Aged; Pancreatic Neoplasms; Spinal Neoplasms | 2022 |
Characterization of S628N: a novel KIT mutation found in a metastatic melanoma.
Topics: Aged, 80 and over; Animals; Benzamides; Cell Transformation, Neoplastic; Cells, Cultured; Colony-Forming Units Assay; Dasatinib; Fatal Outcome; Female; Fibroblasts; Humans; Imatinib Mesylate; Lung Neoplasms; Melanoma; Mutation, Missense; Phosphorylation; Piperazines; Point Mutation; Proto-Oncogene Proteins c-kit; Pyrimidines; Rats; Skin Neoplasms; Spinal Neoplasms; Thiazoles | 2014 |
Bone marrow necrosis secondary to imatinib usage, mimicking spinal metastasis on magnetic resonance imaging and FDG-PET/CT.
Topics: Aged; Antineoplastic Agents; Benzamides; Bone Marrow; Bone Marrow Diseases; Diagnosis, Differential; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Multimodal Imaging; Necrosis; Piperazines; Positron-Emission Tomography; Pyrimidines; Spinal Neoplasms; Tomography, X-Ray Computed | 2012 |
An immunohistochemical evaluation of c-kit (CD-117) expression in malignant melanoma, and results of imatinib mesylate (Gleevec) therapy in three patients.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Humans; Imatinib Mesylate; Immunohistochemistry; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Spinal Neoplasms; Treatment Outcome | 2005 |